Anadys Pharmaceuticals
San Diego
About Anadys Pharmaceuticals
Anadys Pharmaceuticals is a biopharmaceutical company that develops novel therapeutics for the treatment of chronic hepatitis C viral infections. The company focuses on the development of ANA598, a direct-acting antiviral (DAA) for the treatment of hepatitis C. It also focuses to resume the clinical development of ANA773, an oral, small-molecule inducer of endogenous interferons that acts via the Toll-like receptor 7 or TLR7. Anadys Pharmaceuticals was founded in 1992 and is headquartered in San Diego, California. As of November 22, 2011, Anadys Pharmaceuticals operates as a subsidiary of Hoffmann-La Roche Inc.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $71.3M
- Funding stage: M&A
- Last round: Private Equity (Aug 2005)
- Website: anadyspharma.com
- Phone: +1 (858)530-3600
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Canonical: https://fsome.com/organization/anadys-pharmaceuticals-2415473 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.